Simultaneous immobilization of glucose oxidase on the surface and cavity of hollow gold nanospheres as labels for highly sensitive electrochemical immunoassay of tumor marker
A novel tracer, glucose oxidase (GOD)-functionalized hollow gold nanospheres encapsulating glucose oxidase (Au shell@GOD), was designed to label the ferrocenemonocarboxylic-grafted secondary antibodies (Fc@Ab 2) for highly sensitive detection of tumor marker using carboxyl group functionalized multi...
Gespeichert in:
Veröffentlicht in: | Biosensors & bioelectronics 2011-01, Vol.26 (5), p.2776-2780 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A novel tracer, glucose oxidase (GOD)-functionalized hollow gold nanospheres encapsulating glucose oxidase (Au
shell@GOD), was designed to label the ferrocenemonocarboxylic-grafted secondary antibodies (Fc@Ab
2) for highly sensitive detection of tumor marker using carboxyl group functionalized multiwall carbon nanotubes as platform. Initially, Au
shell@GOD was synthesized specially by reverse micelle approach, and then the labeling of antibody and the preparation of GOD-functionalized Au
shell@GOD were performed by one-pot assembly of Fc@Ab
2 and GOD on the surface of Au
shell@GOD. The ferrocene used to label antibodies acted as a mediator of electron transfer between GOD and electrode surface. The high-content glucose oxidase in the tracer (on the surface and in the cavity) could significantly amplify the amperometric signal for sandwich-type immunoassay. Using carcinoembryonic antigen (CEA) as model analyte, the designed tracer showed linear range from 0.02 to 5.0
ng
mL
−1 with the detection limit down to 6.7
pg
mL
−1. The assay results of serum samples with the proposed method were in an acceptable agreement with the reference values. The new protocol showed acceptable stability and reproducibility, high sensitivity, and good precision, which could provide a promising potential for clinical screening and diagnosis of tumor disease. |
---|---|
ISSN: | 0956-5663 1873-4235 |
DOI: | 10.1016/j.bios.2010.10.039 |